Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Terbutaline 500micrograms/dose dry powder inhaler
0301011V0AABBBB
|
Terbutaline sulfate | Terbutaline sulphate | Respiratory System | 65,499 |
|
Terbutaline 5mg/2ml nebuliser liquid unit dose vials
0301011V0AAADAD
|
Terbutaline sulfate | Terbutaline sulphate | Respiratory System | 1,482 |
|
Terbutaline 5mg tablets
0301011V0AAAHAH
|
Terbutaline sulfate | Terbutaline sulphate | Respiratory System | 280 |
|
Terbutaline 2.5mg/5ml solution for injection ampoules
0301011V0AAAKAK
|
Terbutaline sulfate | Terbutaline sulphate | Respiratory System | 138 |
|
Terbutaline 500micrograms/1ml inj ampoules
0301011V0AAABAB
|
Terbutaline sulfate | Terbutaline sulphate | Respiratory System | 26 |
|
Terbutaline 1.5mg/5ml oral solution sugar free
0301011V0AAAGAG
|
Terbutaline sulfate | Terbutaline sulphate | Respiratory System | No data available |
|
Terbutaline 10mg/ml nebuliser liquid
0301011V0AAAXAX
|
Terbutaline sulfate | Terbutaline sulphate | Respiratory System | No data available |
|
Terbutaline 250micrograms/dose inhaler
0301011V0AAAAAA
|
Terbutaline sulfate | Terbutaline sulphate | Respiratory System | No data available |
|
Terbutaline 250micrograms/dose inhaler with spacer
0301011V0AAAFAF
|
Terbutaline sulfate | Terbutaline sulphate | Respiratory System | No data available |
|
Terbutaline 7.5mg modified-release tablets
0301011V0AAAIAI
|
Terbutaline sulfate | Terbutaline sulphate | Respiratory System | No data available |
|
Terbutaline 7.5mg/15ml inf pre-filled syringes
0301011V0AABABA
|
Terbutaline sulfate | Terbutaline sulphate | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.